The allergy treatment market has rapidly evolved over the past few decades on the back of the growing interprofessional approach to its diagnosis. Severe symptoms manifest themselves in anaphylaxis. A wide range of triggers include but not limited to bee stings, peanuts, latex, and small molecule and immune drugs. Allergy pathophysiology has greatly contributed to the growth of the allergy treatment market. Life-threatening symptoms, include increased vascular permeability, facial flushing, and bronchoconstriction.
Over the years, the incidence of allergy has risen swiftly. The growing body of studies shedding light on the etiology and the pathophysiology is the hinge around which propositions of promising treatments have been marketed. This stands as a key enabler for the allergy treatment market. In particular, allergen-specific immunotherapies (also known as desensitization) have made rapid advancements.
Immunotherapy is a key segment. Some of the key immunotherapies industry players in the allergy treatment market are subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). Anti-allergy drugs are another treatment therapy segment replete with opportunities and have been scrutinized in the allergy treatment market. The key distribution channels covered in the study.
In several developed nations, the prevalence of allergy poses a glaring concern. According to an article published in the NCBI, the lifetime prevalence of anaphylaxis is 1.6%. In industrialized nations, the statistic is 0.5 and 2 percent. In children, the prevalence of allergic atopic dermatitis is significant. The overall prevalence has increased over the past three decades in the industrialized world. The global valuation of the allergy treatment market is projected to advance at CAGR of 5.5% during the forecast period 2017 – 2025.
The key allergy types covered in the allergy treatment market are from food, inhaled, and drugs. Of these, inhaled allergy leading allergy held a leading share. Some of the key allergy types due to inhalation are allergic asthma and allergic rhinitis/conjunctivitis.
Also, food allergy has been extensively targeted for revenue generation. Enormous study on standard of care for food allergies has propelled the allergy treatment market.
The trend of food allergies becoming growing public health concern is a key driver for sales avenues for products in the market. Strides in this segment have led to the use of a number of tools that are used in the diagnosis of food allergies.
In children, the prevalence of food allergy high, the reason having perhaps to do with the fact that they can be allergic to a range of food, mainly including cow’s milk, peanut, shellfish, egg, fin fish, tree nuts, wheat, and soy. Pediatrics are thus expanding the knowledge about diagnosis, management, and referral, notably pathogenesis of IgE-mediated food allergies. Advances in Allergen-specific IgE (sIgE) testing are propelling the expansion of the allergy treatment market. Key types of tests done to clinically confirm food allergy are skin prick testing and sIgE.
A number of indications are used as first line and adjunctive treatments are the use of antihistamines, albuterol, and steroids. Extensive R&D in injectable epinephrine has enriched the treatment of anaphylaxis, thereby boosting the allergy treatment market. A number of quality-of-life surveys have been conducted in children with food allergies have paved way to lucrative avenues for pharmaceutical companies and other industry players in the market. In this regard, a number of clinical trials oral immunotherapy have offered tailwind to the allergy treatment market. In particular, multiple food oral immunotherapy has been extensively studied in developed nations notably in Europe and the U.S.
The growing prevalence of allergic rhinitis (AR) around the world has spurred researchers to explore new approaches for severity and duration of symptoms. The prevalence is noticeable in the U.S. It is estimated to be 10-30% in adults and almost 40% in children.
Companies in the allergy treatment market have reaped lucrative gains from the proven effectiveness of immunotherapy for allergic conditions including AR. Of note, industry players have enriched the value chain by focusing on improving the patients' compliance, safety and efficacy, and affordability of the chosen treatment option.
Updates in guidelines are continuously expanding the avenue for players in the allergy treatment market. Particularly, the guidelines by Allergic Rhinitis and Its Impact on Asthma (ARIA) have proved to be helpful. The growing demand for new therapies for the management of AR is a key driver for revenue growth for players in the market. The severity of AR has shown a positive association with asthma.
Some of the pharmacological treatments generating revenue potential in the allergy treatment market are oral antihistamines, Intranasal antihistamines, Intranasal corticosteroids, and leukotriene receptor antagonists (LTRAs).
A vast avenue stems from R&D in sublingual immunotherapy (SLIT). The several benefits of SLIT have propelled the popularity, especially for treating patients in North America. For instance, this has been found to be effective in Canada for grass and ragweed allergies and certain allergic rhinitis. Several trails including randomized clinical trials (RCTs) have been done in allergen-specific immunotherapy, thereby expanding the value chain in the allergy treatment market. Overall, the presence of a large value chain and continued R&D in advancing the efficacy of immunotherapies have opened new revenues streams in North America.
The North America allergy treatment market held the major share in 2016. The prevalence of allergy especially in children has bolstered the revenue prospects of the regional market. The unmet need of allergen-specific immunotherapy in Canada is expected to open new avenues for players in the market.
Some of the key players in the allergy treatment market are Stallergenes Greer, GlaxoSmithKline plc., ALK-Abelló A/S, Teva Pharmaceutical, HAL Allergy Group, Allergan, Allergon AB, Sunovion Pharmaceuticals Inc., Allergy Therapeutics, and Meda Pharmaceuticals Inc.
The global Allergy treatment market is segmented as given below:
|
by Allergy Type |
|
|
by Treatment |
|
|
by Distribution Channel |
|
|
by Major Region |
|
Allergy treatment market is anticipated to grow at a CAGR of 5.5% during the forecast period
North America accounted for a major share of the global allergy treatment market
2017 is the base year calculated in allergy treatment market report
The global allergy treatment market is likely to be driven by the growing need to meet the huge unmet demand in developing parts of the world and rising prevalence of asthma
Key players in the global allergy treatment market include Schering-Plough Corporation, McNeil Consumer Healthcare, GlaxoSmithKline plc, Allergan plc, Collegium Pharmaceutical, Inc., and Allergy Therapeutics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Allergy Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Allergy Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Key Market Indicators
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunity
4.5. Global Allergy Treatment Market Analysis and Forecasts, 2015–2025
4.6. Porter’s Five Force Analysis
4.7. Market Outlook
4.8. Global Prevalence of Allergies, By Type
4.9. Global Prevalence of Food Allergies, By Region
5. Global Allergy Treatment Market Analysis and Forecasts, By Allergy Type
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Value Forecast by Allergy Type, 2015–2025
5.4.1. Food Allergy
5.4.2. Inhaled Allergy
5.4.3. Drug Allergy
5.4.4. Others
5.5. Market Attractiveness by Allergy Type
6. Global Allergy Treatment Market Analysis and Forecasts, By Treatment
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Value Forecast by Treatment, 2015–2025
6.4.1. Anti-allergy Drugs
6.4.1.1. Antihistamines
6.4.1.2. Corticosteroids
6.4.1.3. Leukotriene Inhibitors
6.4.1.4. Others
6.4.2. Immunotherapy
6.4.2.1. Subcutaneous Immunotherapy (SCIT)
6.4.2.2. Sublingual Immunotherapy (SLIT)
6.5. Market Attractiveness by Treatment
7. Global Allergy Treatment Market Analysis and Forecasts, By Distribution Channels
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Value Forecast by Distribution Channels, 2015–2025
7.4.1. Hospital Pharmacies
7.4.2. Online Pharmacies
7.4.3. Retail Pharmacies & Drug Stores
7.5. Market Attractiveness by Distribution Channels
8. Global Allergy Treatment Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Key Policies
8.3. Market Value Forecast by Region
8.3.1. North America
8.3.2. Europe
8.3.3. Asia Pacific
8.3.4. Latin America
8.3.5. Middle East & Africa
8.4. Market Attractiveness by Country
9. North America Allergy Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.1.2. Key Trends
9.2. Market Value Forecast by Allergy Type, 2015–2025
9.2.1. Food Allergy
9.2.2. Inhaled Allergy
9.2.3. Drug Allergy
9.2.4. Others
9.3. Market Value Forecast by Treatment, 2015–2025
9.3.1. Anti-allergy Drugs
9.3.1.1. Antihistamines
9.3.1.2. Corticosteroids
9.3.1.3. Leukotriene Inhibitors
9.3.1.4. Others
9.3.2. Immunotherapy
9.3.2.1. Subcutaneous Immunotherapy (SCIT)
9.3.2.2. Sublingual Immunotherapy (SLIT)
9.4. Market Value Forecast by Distribution Channels, 2015–2025
9.4.1. Hospital Pharmacies
9.4.2. Online Pharmacies
9.4.3. Retail Pharmacies & Drug Stores
9.5. Market Value Forecast by Country, 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Allergy Type
9.6.2. By Treatment
9.6.3. By Distribution Channels
9.6.4. By Country
10. Europe Allergy Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.1.2. Policies and Regulations
10.1.3. Key Trends
10.2. Market Value Forecast by Allergy Type, 2015–2025
10.2.1. Food Allergy
10.2.2. Inhaled Allergy
10.2.3. Drug Allergy
10.2.4. Others
10.3. Market Value Forecast by Treatment, 2015–2025
10.3.1. Anti-allergy Drugs
10.3.1.1. Antihistamines
10.3.1.2. Corticosteroids
10.3.1.3. Leukotriene Inhibitors
10.3.1.4. Others
10.3.2. Immunotherapy
10.3.2.1. Subcutaneous Immunotherapy (SCIT)
10.3.2.2. Sublingual Immunotherapy (SLIT)
10.4. Market Value Forecast by Distribution Channels, 2015–2025
10.4.1. Hospital Pharmacies
10.4.2. Online Pharmacies
10.4.3. Retail Pharmacies & Drug Stores
10.5. Market Value Forecast by Country, 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Italy
10.5.5. Spain
10.5.6. Russia
10.5.7. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Allergy Type
10.6.2. By Treatment
10.6.3. By Distribution Channels
10.6.4. By Country
11. Asia Pacific Allergy Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.1.2. Policies and Regulations
11.1.3. Price Trend Analysis
11.1.4. Key Trends
11.2. Market Value Forecast by Allergy Type, 2015–2025
11.2.1. Food Allergy
11.2.2. Inhaled Allergy
11.2.3. Drug Allergy
11.2.4. Others
11.3. Market Value Forecast by Treatment, 2015–2025
11.3.1. Anti-allergy Drugs
11.3.1.1. Antihistamines
11.3.1.2. Corticosteroids
11.3.1.3. Leukotriene Inhibitors
11.3.1.4. Others
11.3.2. Immunotherapy
11.3.2.1. Subcutaneous Immunotherapy (SCIT)
11.3.2.2. Sublingual Immunotherapy (SLIT)
11.4. Market Value Forecast by Distribution Channels, 2015–2025
11.4.1. Hospital Pharmacies
11.4.2. Online Pharmacies
11.4.3. Retail Pharmacies & Drug Stores
11.5. Market Value Forecast by Country, 2015–2025
11.5.1. China
11.5.2. India
11.5.3. Japan
11.5.4. Australia & New Zealand
11.5.5. Vietnam
11.5.6. South Korea
11.5.7. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Allergy Type
11.6.2. By Treatment
11.6.3. By Distribution Channels
11.6.4. By Country
12. Latin America Allergy Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.1.2. Policies and Regulations
12.1.3. Key Trends
12.2. Market Value Forecast by Allergy Type, 2015–2025
12.2.1. Food Allergy
12.2.2. Inhaled Allergy
12.2.3. Drug Allergy
12.2.4. Others
12.3. Market Value Forecast by Treatment, 2015–2025
12.3.1. Anti-allergy Drugs
12.3.1.1. Antihistamines
12.3.1.2. Corticosteroids
12.3.1.3. Leukotriene Inhibitors
12.3.1.4. Others
12.3.2. Immunotherapy
12.3.2.1. Subcutaneous Immunotherapy (SCIT)
12.3.2.2. Sublingual Immunotherapy (SLIT)
12.4. Market Value Forecast by Distribution Channels, 2015–2025
12.4.1. Hospital Pharmacies
12.4.2. Online Pharmacies
12.4.3. Retail Pharmacies & Drug Stores
12.5. Market Value Forecast by Country, 2015–2025
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Allergy Type
12.6.2. By Treatment
12.6.3. By Distribution Channels
12.6.4. By Country
13. Middle East & Africa Allergy Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.1.2. Policies and Regulations
13.1.3. Key Trends
13.2. Market Value Forecast by Allergy Type, 2015–2025
13.2.1. Food Allergy
13.2.2. Inhaled Allergy
13.2.3. Drug Allergy
13.2.4. Others
13.3. Market Value Forecast by Treatment, 2015–2025
13.3.1. Anti-allergy Drugs
13.3.1.1. Antihistamines
13.3.1.2. Corticosteroids
13.3.1.3. Leukotriene Inhibitors
13.3.1.4. Others
13.3.2. Immunotherapy
13.3.2.1. Subcutaneous Immunotherapy (SCIT)
13.3.2.2. Sublingual Immunotherapy (SLIT)
13.4. Market Value Forecast by Distribution Channels, 2015–2025
13.4.1. Hospital Pharmacies
13.4.2. Online Pharmacies
13.4.3. Retail Pharmacies & Drug Stores
13.5. Market Value Forecast by Country, 2015–2025
13.5.1. GCC Countries
13.5.2. South Africa
13.5.3. Rest of Middle East & Africa
13.6. Market Attractiveness Analysis
13.6.1. By Allergy Type
13.6.2. By Treatment
13.6.3. By Distribution Channels
13.6.4. By Country
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis by Company (2016)
14.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.3.1. ALK
14.3.1.1. Financial Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. Stallergenes Greer
14.3.2.1. Financial Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. Allergy Therapeutics
14.3.3.1. Financial Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. HAL Allergy Group
14.3.4.1. Financial Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Circassia
14.3.5.1. Financial Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. GlaxoSmithKline plc
14.3.6.1. Financial Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Sunovion Pharmaceuticals, Inc. (Sumitomo Dainippon Pharma Co., Ltd.)
14.3.7.1. Financial Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Teva Pharmaceutical Industries Ltd.
14.3.8.1. Financial Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Allergan plc
14.3.9.1. Financial Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Allergon AB (Thermo Fisher Scientific, Inc.)
14.3.10.1. Financial Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. Meda Pharmaceuticals, Inc. (Meda AB)
14.3.11.1. Financial Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
List of Tables
Table 01: Global Prevalence of Food & Inhaled Allergies, By Country, 2014
Table 02: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 03: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2015–2025
Table 04: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment – Anti-allergy Drugs, 2015–2025
Table 05: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment – Immunotherapy, 2015–2025
Table 06: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 07: Global Allergy Treatment Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 10: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2015–2025
Table 11: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Anti-allergy Drug, 2015–2025
Table 12: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Immunotherapy, 2015–2025
Table 13: North America Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 14: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 15: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 16: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2015–2025
Table 17: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Anti-allergy Drug, 2015–2025
Table 18: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Immunotherapy, 2015–2025
Table 19: Europe Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 20: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 21: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 22: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2015–2025
Table 23: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Anti-allergy Drug, 2015–2025
Table 24: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Immunotherapy, 2015–2025
Table 25: Asia Pacific Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 26: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 27: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 28: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2015–2025
Table 29: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment – Anti-allergy Drugs, 2015–2025
Table 30: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment – Immunotherapy, 2015–2025
Table 31: Latin America Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
Table 32: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 33: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Allergy Type, 2015–2025
Table 34: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment, 2015–2025
Table 35: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment – Anti-allergy Drugs, 2015–2025
Table 36: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Treatment – Immunotherapy, 2015–2025
Table 37: Middle East & Africa Allergy Treatment Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
List of Figures
Figure 01: Global Allergy Treatment Market Size (US$ Mn) Forecast, 2015–2025
Figure 02: Market Value Share, by Allergy Type (2016)
Figure 03: Market Value Share, by Treatment (2016)
Figure 04: Market Value Share, by Distribution Channel (2016)
Figure 05: Market Value Share, by Region (2016)
Figure 06: Global Prevalence of Food Allergies, By Region, 2011
Figure 07: Global Allergy Treatment Market Value Share, by Allergy Type, 2017 and 2025
Figure 08: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Food Allergy, 2015–2025
Figure 09: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Inhaled Allergy, 2015–2025
Figure 10: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Drug Allergy, 2015–2025
Figure 11: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 12: Global Allergy Treatment Market Attractiveness, by Allergy Type, 2027-2025
Figure 13: Global Allergy Treatment Market Value Share, by Treatment, 2017 and 2025
Figure 14: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Anti-allergy Drugs, 2015–2025
Figure 15: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Immunotherapy, 2015–2025
Figure 16: Global Allergy Treatment Market Attractiveness, by Treatment, 2017-2025
Figure 17: Global Allergy Treatment Market Value Share, by Distribution Channel, 2017 and 2025
Figure 18: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacies,
Figure 19: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Retail Pharmacies & Drug Stores, 2015–2025
Figure 20: Global Allergy Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Pharmacies,
Figure 21: Global Allergy Treatment Market Attractiveness, by Distribution Channel, 2017-2025
Figure 22: Global Allergy Treatment Market Value Share, by Region, 2017 and 2025
Figure 23: Global Allergy Treatment Market Attractiveness, by Region, 2017-2025
Figure 24: North America Allergy Treatment Market Value Share, by Country, 2017 and 2025
Figure 25: North America Allergy Treatment Market Value Share, by Allergy Type, 2017 and 2025
Figure 26: North America Allergy Treatment Market Value Share, by Treatment, 2017 and 2025
Figure 27: North America Allergy Treatment Market Value Share, by Distribution Channel, 2017 and 2025
Figure 28: North America Allergy Treatment Market Attractiveness, by Country, 2017-2025
Figure 29: North America Allergy Treatment Market Attractiveness, by Allergy Type, 2017-2025
Figure 30: North America Allergy Treatment Market Attractiveness, by Treatment, 2017-2025
Figure 31: North America Allergy Treatment Market Attractiveness, by Distribution Channel, 2017-2025
Figure 32: Europe Allergy Treatment Market Value Share, by Country, 2017 and 2025
Figure 33: Europe Allergy Treatment Market Value Share, by Allergy Type, 2017 and 2025
Figure 34: Europe Allergy Treatment Market Value Share, by Treatment, 2017 and 2025
Figure 35: Europe Allergy Treatment Market Value Share, by Distribution Channel, 2017 and 2025
Figure 36: Europe Allergy Treatment Market Attractiveness, by Country, 2017-2025
Figure37: Europe Allergy Treatment Market Attractiveness, by Allergy Type, 2017-2025
Figure 38: Europe Allergy Treatment Market Attractiveness, by Treatment, 2017-2025
Figure39: Europe Allergy Treatment Market Attractiveness, by Distribution Channel, 2017-2025
Figure 40: Asia Pacific Allergy Treatment Market Value Share, by Country, 2017 and 2025
Figure 41: Asia Pacific Allergy Treatment Market Value Share, by Allergy Type, 2017 and 2025
Figure 42: Asia Pacific Allergy Treatment Market Value Share, by Treatment, 2017 and 2025
Figure 43: Asia Pacific Allergy Treatment Market Value Share, by Distribution Channel, 2017 and 2025
Figure 44: Asia Pacific Allergy Treatment Market Attractiveness, by Country, 2017-2025
Figure 45: Asia Pacific Allergy Treatment Market Attractiveness, by Allergy Type, 2017-2025
Figure 46: Asia Pacific Allergy Treatment Market Attractiveness, by Treatment, 2017-2025
Figure 47: Asia Pacific Allergy Treatment Market Attractiveness, by Distribution Channel, 2017-2025
Figure 48: Latin America Allergy Treatment Market Value Share, by Country, 2017 and 2025
Figure 49: Latin America Allergy Treatment Market Value Share, by Allergy Type, 2017 and 2025
Figure 50: Latin America Allergy Treatment Market Value Share, by Treatment, 2017 and 2025
Figure 51: Latin America Allergy Treatment Market Value Share, by Distribution Channel, 2017 and 2025
Figure 52: Latin America Allergy Treatment Market Attractiveness, by Country, 2017-2025
Figure 53: Latin America Allergy Treatment Market Attractiveness, by Allergy Type, 2017-2025
Figure 54: Latin America Allergy Treatment Market Attractiveness, by Treatment, , 2017-2025
Figure 55: Latin America Allergy Treatment Market Attractiveness, by Distribution Channel, , 2017-2025
Figure 56: Middle East & Africa Allergy Treatment Market Value Share, by Country, 2017 and 2025
Figure 57: Middle East & Africa Allergy Treatment Market Value Share, by Allergy Type, 2017 and 2025
Figure 58: Middle East & Africa Allergy Treatment Market Value Share, by Treatment, 2017 and 2025
Figure 59: Middle East & Africa Allergy Treatment Market Value Share, by Distribution Channel, 2017 and 2025
Figure 60: Middle East & Africa Allergy Treatment Market Attractiveness, by Country, 2017-2025
Figure 61: Middle East & Africa Allergy Treatment Market Attractiveness, by Allergy Type, 2017-2025
Figure 62: Middle East & Africa Allergy Treatment Market Attractiveness, by Treatment, 2017-2025
Figure 63: Middle East & Africa Allergy Treatment Market Attractiveness, by Distribution Channel, 2017-2025
Figure 64: Global Immunotherapy in Allergy Treatment Market Share, by Company, 2016
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Allergy Treatment Market Insights, 2017-2025
*86 figures and 60 tables includes